Dec 4, 2020 | News, Oligonucleotides
This interview was originally published in the December issue of CHEManager. Bachem’s Large-Scale Facility to Come Online in 2021 The global market for oligonucleotide therapeutics is expanding rapidly. Bachem, an innovation-driven company based in Bubendorf,...
Are you ready to dive into the fascinating universe of peptides and oligonucleotides?
Sign up for our newsletter and receive the latest updates directly in your inbox.
"*" indicates required fields